Bausch Health Companies Inc.  (NYSE: BHC) Securities Fraud Class Action

Bausch Health Companies Inc. (NYSE: BHC) Securities Fraud Class Action

CompanyBausch Health Companies Inc.
CourtUnited States District Court for the District of New Jersey
Case Number23-cv-03996
JudgeHonorable Zahid N. Quraishi
Class PeriodMay 7, 2020 through June 8, 2023
Security TypeSecurities

Case Background:
This is a federal securities fraud class action lawsuit on behalf of those that purchased or otherwise acquired Bausch Health Companies Inc. (“Bausch”) (NYSE: BHC) securities between May 7, 2020 and June 8, 2023, inclusive (the “Class Period”).

The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Bausch & Lomb (“B+L”) spinoff would not result in two strong separate companies; (2) without B+L, Bausch was left overly leveraged and without the cashflow generated by B+L; (3) distribution of the B+L spinoff shares would not occur as represented; (4) the above statements omitted and/or concealed the potential damages Bausch faced from the Opt-Out Plaintiffs; (5) the spinoff was not intended to benefit Bausch shareholders but instead designed to subvert the Opt-Out Plaintiffs’ lawsuit against the company; and (6) as a result of the foregoing, Defendants’ statements about the company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Current Status of Case:
On November 20, 2025, the District Court granted Defendants’ Motion to Dismiss the Amended Complaint. On December 22, 2025, the Lead Plaintiffs appealed the dismissal to the United States Court of Appeals for the Third Circuit Court. The appeal is currently being briefed by the parties. This action is ongoing.

If you wish to discuss this action or have any questions, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at [email protected]. If you would like additional information about the suit, please click on the link “Submit Your Information” above and fill out the form as promptly as possible.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs’ Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent. 

Complete this form with your transactions in Bausch Health Companies Inc. between May 7, 2020 through June 8, 2023.

    Submit Your Information
    SUBMIT YOUR INFORMATION
    * Denotes required field
    Phone Country code
    Purchase Information
    Sales Information
    Did you purchase shares of Bausch Health Companies Inc. prior to the Class Period?
    Are you a current or former employee of Bausch Health Companies Inc. ?
    The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. READ MORE
    I agree to the KTMC disclaimer
    I would like to receive new case alerts by email
    Scroll to Top